Providers March on U.S. Capitol Grounds to “Defend 340B”

340B program advocates with signs in front of the US Capitol building
Safety-net provider advocates marched on the U.S. Capitol grounds yesterday to raise awareness about threats to the 340B drug pricing program.

About 100 safety-net provider advocates marched and chanted yesterday on the grounds of the U.S. Capitol to raise awareness in Congress and beyond about threats to the 340B drug pricing program.

The demonstration, organized by Community Voices for 340B (CV340B),

Read More »

Ex-Surgeon General Adams Urges 340B Entities to Publicize Program’s Benefits

Former U.S. Surgeon General Jerome Adams speaking at a conference
Ex-U.S. Surgeon General Jerome Adams urged 340B Coalition summer conference attendees to show they "are fighting to deliver care to the vulnerable and to the underserved." | Credit: 340B Coalition Twitter

Healthcare providers can suppress attacks on and build support for the 340B program by doing more to show the program helps vulnerable patients, the anesthesiologist who served as President Trump’s surgeon general said yesterday.

“We are fighting to deliver care

Read More »

340B Hospitals Ask Judge to Stop Part B Drug Payment Cuts Immediately

hypodermic needle and glass ampule
Groups that represent 340B hospitals asked a federal district judge to immediately halt a nearly 30% Medicare Part B payment cut for hospitals’ 340B-purchased drugs.

Groups that represent 340B hospitals yesterday asked a federal district judge in Washington, D.C., to immediately halt a nearly 30% Medicare Part B payment cut in place since 2018 for hospitals’ 340B-purchased drugs.

American Hospital Association, America’s Essential Hospitals, Association

Read More »

New PhRMA-Funded Study Questions 340B Hospital Eligibility Yardstick

bar charts of percent of claims of inpatients and outpatients in 2020
New PhRMA-funded research shows that Medicare beneficiaries who were inpatients at 340B DSH hospitals were approximately 35% more likely to have the Part D Low Income Subsidy (LIS) and to be dually eligible for Medicare and Medicaid than were beneficiaries served on an outpatient basis.

Patients receiving inpatient care at 340B disproportionate share hospitals are significantly more likely to be low income than those receiving outpatient care, according to a new study funded by the brand name drug trade group PhRMA.

Hospital eligibility in the

Read More »

340B INDUSTRY LEADER SPOTLIGHT

William A. Riley, Senior Director, Health Systems Solutions & Decision Science, AllianceRx Walgreens Pharmacy

William A. Riley headshot
William A. Riley, Senior Director, Health Systems Solutions & Decision Science, AllianceRx Walgreens Pharmacy
William A. Riley

Q: Where did you grow up?

I had the honor to grow up with both of my parents serving in the Air Force so we did move around a fair amount in my younger years. However, I spent the majority of my childhood in Tuscola, IL, just 30 minutes from Champaign, home of University of Illinois.

Q:

Read More »

Purdue Pharma Is Providing 340B Refunds Spanning 16 Years of Overcharges

A bottle of Betasept antiseptic scrub
Purdue Pharma announced refunds for 340B overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—more than half of the 340B program's existence.

Purdue Pharma’s Avrio Health subsidiary is giving 340B covered entities refunds for overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—from Q2 2005 through Q2 2021. That period covers more than half of the 340B program’s existence.

During

Read More »

340B Coalition Conference Speakers to Providers: Give Us Your Success Stories

large projection of HRSA Administrator Carol Johnson speaking at a podium
“It’s really important to us, and it’s really important to you all … that you tell the story of 340B,” HRSA Administrator Carole Johnson told entities yesterday at the 340B Coalition summer conference.

Top federal 340B program officials and the head of a 340B hospital group yesterday urged covered entity representatives attending a meeting near Washington, D.C., to focus on documenting and telling their 340B success stories.

The need to show that 340B

Read More »

340B Hospitals Treat Bigger Shares of Underserved Patients than Non-340B Hospitals and Clinics, Study Finds

bar chart depicting 3 characteristics of patients receiving part B drugs in 2019
340B hospitals treat higher shares of patients who are dually eligible for Medicare and Medicaid, Medicare patients with disabilities, and Medicare patients under 65, a new study found.

A new study, conducted by L&M Policy Research on behalf of 340B Health, finds hospitals participating in the 340B program treat much higher shares of underserved patients than non-340B hospitals and physicians’ offices. The study was released on July 29. 

Researchers

Read More »

Senate Democrats Say They Are on Track to Pass Drug Pricing Bill Before Aug. 8

U.S. Senate chamber viewed from public gallery
Senate Democrats are still pushing to pass drug pricing legislation before the chamber begins its summer break on Aug. 8.

Senate Democrats said yesterday they would know this week whether an updated Senate drug pricing bill meets the criteria for passage via budget reconciliation, which requires just 50 Democratic votes. The bill remains on track for a floor vote before

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Scott LaChute, Vice President of Operations, Verity Solutions

Scott LaChute headshot
Scott LaChute, Vice President of Operations, Verity Solutions
Scott LaChute

Q: Where did you grow up?

I grew up in New Orleans as a young child and then in Brazil during most of my teens.

Q: Where did you go to college?

I went to Loyola University for undergrad and majored in business management/accounting;. Then I went on to Western Governors University in Utah for my masters

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live